tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NERV Stock Latest News

Closing Bell Movers: UiPath up nearly 4% after S&P 400 admission
The FlyClosing Bell Movers: UiPath up nearly 4% after S&P 400 admission
3d ago
AMZN
GOOG
Minerva files to sell 94.6M shares of common stock for holders
PremiumThe Fly
Minerva files to sell 94.6M shares of common stock for holders
3d ago
NERV
Minerva Neurosciences Shareholders Approve Key Governance Measures
PremiumCompany Announcements
Minerva Neurosciences Shareholders Approve Key Governance Measures
4d ago
8K
NERV
Minerva price target raised to $5 from $3 at Jefferies
PremiumThe Fly
Minerva price target raised to $5 from $3 at Jefferies
25d ago
NERV
Minerva Neurosciences Expands Board Amid Fundraising Effort
PremiumCompany Announcements
Minerva Neurosciences Expands Board Amid Fundraising Effort
1M ago
8K
NERV
Minerva appoints Kaul to board of directors
PremiumThe FlyMinerva appoints Kaul to board of directors
1M ago
NERV
Minerva Neurosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Minerva Neurosciences Reports Q3 2025 Financial Results
2M ago
NERV
Minerva price target lowered to $4 from $5 at H.C. Wainwright
Premium
The Fly
Minerva price target lowered to $4 from $5 at H.C. Wainwright
2M ago
NERV
Minerva reports Q3 EPS (36c) vs $2.97 last year
PremiumThe Fly
Minerva reports Q3 EPS (36c) vs $2.97 last year
2M ago
NERV
Minerva Neurosciences Secures $200M for Drug Trials
PremiumCompany Announcements
Minerva Neurosciences Secures $200M for Drug Trials
2M ago
8K
NERV
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
GM
KO
Why Is Minerva Neurosciences Stock (NERV) Up 165% Today?
PremiumMarket News
Why Is Minerva Neurosciences Stock (NERV) Up 165% Today?
2M ago
NERV
Minerva announces financing of up to $200M to advance roluperidone
PremiumThe FlyMinerva announces financing of up to $200M to advance roluperidone
2M ago
NERV
Minerva Neurosciences Reports Q2 2025 Financial Results
Premium
Company Announcements
Minerva Neurosciences Reports Q2 2025 Financial Results
4M ago
NERV
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NERV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
NERV
Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
PremiumCompany Announcements
Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges
7M ago
NERV
Minerva reports Q1 EPS (50c) vs ($1.13) last year
PremiumThe Fly
Minerva reports Q1 EPS (50c) vs ($1.13) last year
8M ago
NERV
NERV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NERV Earnings this Week: How Will it Perform?
8M ago
NERV
Minerva Neurosciences Reports Improved 2024 Financials
PremiumCompany Announcements
Minerva Neurosciences Reports Improved 2024 Financials
10M ago
NERV
Hold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
PremiumRatingsHold Rating for Minerva Neurosciences Amidst Uncertainty Over Roluperidone and Financial Constraints
10M ago
NERV
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
Premium
The Fly
Minerva reports Q4 EPS (56c) vs. ($1.19) last year
10M ago
NERV
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
Premium
Company Announcements
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
1y ago
NERV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >